Thermo Fisher Scientific Inc. (TMO)
TMO Stock Price Chart
Explore Thermo Fisher Scientific Inc. interactive price chart. Choose custom timeframes to analyze TMO price movements and trends.
TMO Company Profile
Discover essential business fundamentals and corporate details for Thermo Fisher Scientific Inc. (TMO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
17 Mar 1980
Employees
125.00k
Website
https://www.thermofisher.comCEO
Marc N. Casper
Description
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
TMO Financial Timeline
Browse a chronological timeline of Thermo Fisher Scientific Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 15 Sept 2026
A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend will be paid on 15 Oct 2026.
Upcoming earnings on 23 Jul 2026
EPS estimate is $5.71, while revenue estimate is $11.71bn.
Dividend declared on 15 Jun 2026
A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend was paid on 15 Jul 2026.
Earnings released on 23 Apr 2026
EPS came in at $5.44 surpassing the estimated $5.25 by +3.62%, while revenue for the quarter reached $11.01bn , beating expectations by +1.29%.
Dividend declared on 13 Mar 2026
A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend was paid on 15 Apr 2026.
Earnings released on 29 Jan 2026
EPS came in at $6.57 surpassing the estimated $6.45 by +1.86%, while revenue for the quarter reached $12.22bn , beating expectations by +2.22%.
Dividend declared on 15 Dec 2025
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 15 Jan 2026.
Earnings released on 22 Oct 2025
EPS came in at $5.79 surpassing the estimated $5.50 by +5.27%, while revenue for the quarter reached $11.12bn , beating expectations by +1.87%.
Dividend declared on 15 Sept 2025
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 15 Oct 2025.
Earnings released on 23 Jul 2025
EPS came in at $5.36 surpassing the estimated $5.23 by +2.49%, while revenue for the quarter reached $10.86bn , beating expectations by +1.62%.
Dividend declared on 13 Jun 2025
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 15 Jul 2025.
Earnings released on 23 Apr 2025
EPS came in at $5.15 surpassing the estimated $5.10 by +0.98%, while revenue for the quarter reached $10.36bn , beating expectations by +1.29%.
Dividend declared on 14 Mar 2025
A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 15 Apr 2025.
Earnings released on 30 Jan 2025
EPS came in at $6.10 surpassing the estimated $5.94 by +2.69%, while revenue for the quarter reached $11.40bn , beating expectations by +1.04%.
Dividend declared on 13 Dec 2024
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 15 Jan 2025.
Earnings released on 23 Oct 2024
EPS came in at $5.28 surpassing the estimated $5.25 by +0.57%, while revenue for the quarter reached $10.60bn , missing expectations by -0.34%.
Dividend declared on 13 Sept 2024
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 15 Oct 2024.
Earnings released on 24 Jul 2024
EPS came in at $5.37 surpassing the estimated $5.12 by +4.88%, while revenue for the quarter reached $10.54bn , beating expectations by +0.34%.
Dividend declared on 14 Jun 2024
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 15 Jul 2024.
Earnings released on 24 Apr 2024
EPS came in at $5.11 surpassing the estimated $4.71 by +8.49%, while revenue for the quarter reached $10.35bn , beating expectations by +1.87%.
Dividend declared on 14 Mar 2024
A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 15 Apr 2024.
Earnings released on 31 Jan 2024
EPS came in at $5.67 surpassing the estimated $5.64 by +0.53%, while revenue for the quarter reached $10.89bn , beating expectations by +1.48%.
Dividend declared on 14 Dec 2023
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 16 Jan 2024.
Earnings released on 25 Oct 2023
EPS came in at $5.69 surpassing the estimated $5.61 by +1.43%, while revenue for the quarter reached $10.57bn , missing expectations by -0.67%.
Dividend declared on 14 Sept 2023
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 13 Oct 2023.
Earnings released on 26 Jul 2023
EPS came in at $5.15 falling short of the estimated $5.43 by -5.16%, while revenue for the quarter reached $10.69bn , missing expectations by -2.67%.
Dividend declared on 14 Jun 2023
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 14 Jul 2023.
Earnings released on 26 Apr 2023
EPS came in at $5.03 surpassing the estimated $4.95 by +1.62%, while revenue for the quarter reached $10.71bn , beating expectations by +0.41%.
Dividend declared on 14 Mar 2023
A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 14 Apr 2023.
Earnings released on 1 Feb 2023
EPS came in at $5.40 surpassing the estimated $5.19 by +4.05%, while revenue for the quarter reached $11.45bn , beating expectations by +9.83%.
Dividend declared on 14 Dec 2022
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 16 Jan 2023.
Earnings released on 26 Oct 2022
EPS came in at $5.08 surpassing the estimated $4.78 by +6.28%, while revenue for the quarter reached $10.68bn , beating expectations by +7.37%.
Dividend declared on 14 Sept 2022
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 14 Oct 2022.
Earnings released on 28 Jul 2022
EPS came in at $5.51 surpassing the estimated $4.99 by +10.42%, while revenue for the quarter reached $10.97bn , beating expectations by +10.06%.
Dividend declared on 14 Jun 2022
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 15 Jul 2022.
Earnings released on 28 Apr 2022
EPS came in at $7.25 surpassing the estimated $6.18 by +17.31%, while revenue for the quarter reached $11.82bn , beating expectations by +10.52%.
Dividend declared on 15 Mar 2022
A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 14 Apr 2022.
Earnings released on 2 Feb 2022
EPS came in at $6.54 surpassing the estimated $5.22 by +25.29%, while revenue for the quarter reached $10.70bn , beating expectations by +1.48%.
Dividend declared on 14 Dec 2021
A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 14 Jan 2022.
Earnings released on 27 Oct 2021
EPS came in at $5.76 surpassing the estimated $4.67 by +23.34%, while revenue for the quarter reached $9.33bn , beating expectations by +12.37%.
Dividend declared on 14 Sept 2021
A dividend of $0.26 per share was announced, adjusted to $0.26. The dividend was paid on 15 Oct 2021.
Earnings released on 28 Jul 2021
EPS came in at $5.60 surpassing the estimated $5.44 by +2.94%, while revenue for the quarter reached $9.27bn , beating expectations by +11.69%.
TMO Stock Performance
Access detailed TMO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
